skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Global Generics & Biosimilars Awards 2021

We are now open for entries!


See below this text for the full list of categories and criteria, please click on the + icon to view the full criteria details for each category.


There is no fee to enter and you can enter multiple (relevant) categories. The activities in question should have taken place between 1 July 2020 – 30 June 2021 and the entry deadline for nominations is July 30, 2021. 


When you are ready to enter, please go to https://www.eventsforce.net/ggba-21 to create an account and start working on your entry. The entry system lets you save your entry as you go, giving you the opportunity to review it before submitting it. 


If you have any questions, please contact Jo Kirkpatrick, jo.kirkpatrick@informa.com who will be happy to help. Remember the entry deadline is July 30,2021.


2021 Categories and Criteria

Please click on the + icon to view the full criteria details for each category.

Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics or biosimilars.

Enter Now

Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.

Enter Now

Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.

Enter Now

Open to any company that generates at least a third, or at least US$250 million, of its annual sales from generics and biosimilars. Qualification for a region is dependent on the headquarters (not tax domicile) of a company’s generics and/or biosimilars business.

Enter Now

Open to any company supplying off-patent active pharmaceutical ingredients (APIs) or intermediates.

Enter Now

Open to any company which has acquired another company that is active in generics and/or biosimilars, or has acquired a portfolio of generic and/or biosimilar products.

Enter Now

Entries may relate to any biosimilar currently marketed, approved or in clinical development, sales and marketing initiatives, distribution agreements or other initiatives aimed at increasing biosimilar usage.

Enter Now

Open to any generics and/or biosimilars alliance, joint venture, distribution agreement, licensing deal or similar that does not involve the acquisition of another company or a portfolio of products.

Enter Now

Humanitarian charity International Health Partners (IHP) has partnered with Generics Bulletin to create this Award. Entries could include: company approach to CSR, implementation, engagement plans, raining & education programmes, compulsory licensing and humanitarian aid donations.

Enter Now

Awarded to recognize outstanding achievements by firms or individuals that work alongside generics and biosimilars manufacturers and suppliers. These could include logistics providers, contract-research organisations, contract-manufacturers, law firms and consultants.

Enter Now

This category allows generics, biosimilars and value-added medicines firms as well as their partnering law firms to highlight outstanding results from their approach to intellectual property and their legal strategy. This could include notable litigation results allowing a competitive advantage or early launch; inventive ways of getting around or invalidating intellectual property; obtaining intellectual property to protect their own products or processes; or ways in which legal strategies or IP approaches from different global jurisdictions have been used as a template elsewhere, showing the benefits of a coordinated international IP strategy.

Enter Now

Open to any member of the senior management team of a firm within the generics or biosimilars industries. Judges will want to see how the entered leaders have best applied company values within the business environment – achieving measured and sustainable growth, driving improved performance, delivering shareholder value, implementing robust strategies, engaging staff, demonstrating market knowledge and true customer insight.

Enter Now

Awarded to identify excellence in the regulatory sphere. This could include innovative approaches to obtaining marketing authorisations, regulatory milestones for individual companies, or developments that represent a wider breakthrough for the global generics and/or biosimilars industries.

Enter Now

Entries in this category could include known molecules that are repurposed for new indications, reformulated in a way that adds value for patients, put together in innovative combinations, or which feature added-value packaging or delivery methods.

Enter Now

Contact us today

For Sponsorship Opportunities contact:

Christopher Keeling
Tel: +44 (0) 7917 647 859
Email: christopher.keeling@informa.com

For all other inquiries:
Jo Kirkpatrick
Tel: +44 (0) 7917 555 986
Email: jo.kirkpatrick@informa.com